SCHEMBL2452489

SCHEMBL2452489

CCCCCC/C=C/OBO/C=C/CCCCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.46
TRPV1 Q8NER1 1/20 0.46
TSHR P16473 2/20 0.41
TERT O14746 3/20 0.41
CYP1A2 P05177 2/20 0.41
MAPT P10636 2/20 0.41
CYP2C19 P33261 2/20 0.41
BLM P54132 2/20 0.41
HSD17B10 Q99714 2/20 0.41
FABP4 P15090 2/20 0.41
PTPN1 P18031 2/20 0.41
PPARG P37231 2/20 0.41
KMT2A Q03164 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2453658 1.00 FAAH (0.46) FAAHTRPV1TSHRTERTCYP1A2
SCHEMBL157038 0.91 TSHR (0.36) FAAHTRPV1TSHRF7F3
SCHEMBL2452490 0.83 FAAH (0.43) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL2452491 0.83 FAAH (0.43) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL12126932 0.83 FAAH (0.43) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL23673186 0.78 FAAH (0.52) FAAHTRPV1TSHRTERTCYP1A2
SCHEMBL9785182 0.78 FAAH (0.52) FAAHTRPV1TSHRTERTCYP1A2
SCHEMBL2057348 0.78 FAAH (0.52) FAAHTRPV1TSHRTERTCYP1A2
SCHEMBL1974180 0.78 FAAH (0.52) FAAHTRPV1TSHRTERTCYP1A2
SCHEMBL9785139 0.78 FAAH (0.52) FAAHTRPV1TSHRTERTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785417-B2 Absorbent hydrophobic boronate galactomannan complexes and process for producing same ARCHER DANIELS MIDLAND CO. (US) 2014-07-22 US disclosed
EP-1888227-B1 USE OF HYDROPHOBIC BORONATE GALACTOMANNAN COMPLEXES AS ABSORBENT MATERIAL ARCHER DANIELS MIDLAND CO (US) 2011-09-14 EP disclosed
US-20100042063-A1 ABSORBENT HYDROPHOBIC BORONATE GALACTOMANNAN COMPLEXES AND PROCESS FOR PRODUCING SAME ARCHER-DANIELS-MIDLAND COMPANY (CA) 2010-02-18 US disclosed
US-20100036337-A1 ABSORBENT HYDROPHOBIC BORONATE GALACTOMANNAN COMPLEXES AND PROCESS FOR PRODUCING SAME ARCHER-DANIELS-MIDLAND COMPANY (US) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036337-A1 ABSORBENT HYDROPHOBIC BORONATE GALACTOMANNAN COMPLEXES AND PROCESS FOR PRODUCING SAME B3GAT3, B4GALT1, ALG1 FAAH 2449/4885TRPV1 3779/4885TSHR 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.